Prolonged vs Intermittent β-lactam Infusions
Author Information
Author(s): Tamma Pranita D, Putcha Nirupama, Suh Yong D, Van Arendonk Kyle J, Rinke Michael L
Primary Institution: Johns Hopkins Medical Institutions
Hypothesis
Does prolonged β-lactam infusions improve clinical outcomes compared to intermittent infusions?
Conclusion
No clinical advantage was observed for prolonged infusion β-lactams.
Supporting Evidence
- Fourteen randomized controlled trials were included in the analysis.
- Prolonged infusion β-lactams were not associated with decreased mortality or clinical cure compared to intermittent infusions.
- Most studies had methodological flaws, impacting the reliability of the results.
Takeaway
This study looked at whether giving antibiotics continuously instead of in bursts helps patients get better. It found that it doesn't really make a difference.
Methodology
A meta-analysis of randomized controlled trials comparing prolonged and intermittent β-lactam infusions.
Potential Biases
Many studies were funded by pharmaceutical companies, raising concerns about reporting bias.
Limitations
Most studies had notable methodological flaws and a limited number of patients with multi-drug resistant Gram-negative infections.
Participant Demographics
Studies included hospitalized patients, with a range of ages and severity of illness.
Statistical Information
P-Value
0.36
Confidence Interval
95% CI: 0.61-1.37
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website